Douglas Kling retweeted
What’s next for #RNAMedicines?
Tomorrow at 9:15 a.m. ET, CEO @ramaiyar joins Chardan’s “RNA Medicines: Transcriptome Engineering” panel to discuss how our OPERA® platform could help shape the next decade of therapeutic innovation. #RNAEditing $KRRO
Douglas Kling retweeted
Thank you @CoachWozniakTE for inviting me out to a gameday at @MSU_Football !! I had an amazing day and look forward to what’s next!!
Douglas Kling retweeted
Thanks to all of my followers, including the deniers as I just passed an amazing milestone (150 K) for an 80 y/o lipidologist who solely posts lipid and CV (including women's info) educational related materials, but who also interacts with questioners. The background photo on my "X" profile is a lipid macromolecule that @lipiddoc and I formulated and had built ~2012 - The were distributed at the @nationallipid meeting in Arizona - they are now hard to find. @ASPCardio @society_eas @escardio @atherosociety @TheEndoSociety @FamilyHeartFdn @fhpatienteurope @MenopauseOrg
Douglas Kling retweeted
Important data from Ethan et al
In general, if an HCM patient does not feel the transition from NSR to AF, this warrants consideration of why, which includes even reassessment of the diagnosis, especially for new onset AF. As shown here almost 90% are symptomatic.
Similar experience as well with the rate of recurrence and failure of rhythm control strategies
Atrial fibrillation recurrence rates in HCM. High rates of recurrence across multiple rhythm control treatment pathways highlighting need for HCM specific AF treatments/ study.
mdpi.com/4132572
@MDPIOpenAccess
Douglas Kling retweeted
As #HispanicHeritageMonth comes to a close, we’re highlighting cardiovascular health awareness and trusted resources for Hispanic and Latino communities.
Explore the @American_Heart Spanish-language dyslipidemia guideline resource: professional.heart.org/en/sc…
#HeartHealth #Health Equity
ALT Family viewing a pamphlet titled "Conoce tus números." The image promotes cardiovascular health awareness and mentions Hispanic Heritage Month. Text emphasizes access to heart health information, listing "Access," "Awareness," "Action," and "Better Heart Health." The bottom features the Amarin logo.
Douglas Kling retweeted
On Saturday, we joined @CureUCD’s 12th Annual #CureTheCycle ride to raise awareness and support the #UCD community. Thank you to all who rode and donated!
This #CheckAmmoniaMonth, you can still help: charity.pledgeit.org/c/9t4pp… $KRRO
Douglas Kling retweeted
@MartinMaronMD presented a deep dive into the global efficacy of aficamten vs placebo from ACACIA-HCM across multiple relevant domains
Paper: ahajournals.org/doi/full/10.…
#HFSA2026
Douglas Kling retweeted
Jim Januzzi presented on a novel TTR and NTproBNP ratio metric --> excellent surrogate marker
Simultaneously published in JACC
jacc.org/doi/10.1016/j.jchf.…
#HFSA2026
#MedIQHFSA2026
Douglas Kling retweeted
Congratulations to our Chief Scientific Officer, @JohnKastelein, for being awarded the @FamilyHeartFdn's Pioneer Award! We celebrated this achievement last weekend by reflecting on his decades of contributions to lipid science and atherosclerotic cardiovascular disease (ASCVD) prevention.
Strong leaders do more than advance a field. They inspire the people around them to think differently, challenge assumptions and pursue new possibilities. We are grateful for the example Prof. Kastelein sets for our team and the next generation of leaders helping to shape the future of lipid management.
Douglas Kling retweeted
We’re heading to Denver for #OTS2026, Oct. 11–14! Our team will present posters P-027 and P-070 on new chemistries that expand the #RNAEditing capabilities of our OPERA® platform. Learn more: 2026oligomeeting.com/ $KRRO
Douglas Kling retweeted
We’ve dosed the first cohort in ANCHOR, our Phase 1/2 trial of KRRO-121, a subcutaneously delivered RNA-editing oligonucleotide (REO), for the potential treatment of #hyperammonemia in people with #UCDs or #hepaticencephalopathy. $KRRO #RNAEditing
Learn more: bit.ly/4rOT4r6
Douglas Kling retweeted
WNO 190:
Salah Tsarni over Mario Carini 10-5 OT.
Very close match, each got a takedown in regulation, then Tsarni gets a takedown, some swipes, and almost the fall in OT.
Douglas Kling retweeted
After a great call with @Coach_JWatts I am blessed to receive an offer from Duke University!!
@WoodridgeFB_
@DaraioJohn
@CoachAve_
Douglas Kling retweeted
Four Blair guys trying to improve every day in the top 7. All top flight players and students.
New Jersey has updated the Class of 2027 Rankings!
@KamsiAwaka0097
@kaywhyte0
@BlakeHargrove20
@peti_rosta
@Amauro0
@AnthonyGonza1ez
@RayFernandez0
@JaydenLau_11
@devinbolden34
@Milak1Myatt
⭐️291 total players listed
Find the full list here:
prephoops.com/new-jersey/ran…
Douglas Kling retweeted
If you want to upgrade your lipid/lipoprotein knowledge Under no circumstances miss this @PeterAttiaMD podcast with the one and only @mdavidsonmd (I would not be who I am without his early friendship and mentoring). peterattiamd.com/michaeldavi… @nationallipid @foundationofnla @society_eas @ASPCardio @escardio @atherosociety @FamilyHeartFdn @TheEndoSociety @fhpatienteurope #cholesterol @NewAmsPharma #apoE #obicetrapib
Douglas Kling retweeted
@KorroBio CEO @Ramaiyar will join fireside chats at Citi on Sept. 9 and Cantor on Sept. 10 to discuss our approach to harnessing endogenous ADAR enzymes designed for precise, transient #RNAediting without permanently altering the genome.
Learn: bit.ly/3TkAFWf
$KRRO
